AAP NCE OCTOBER 20-24, 2023 in Washington, DC!

RSV MONOCLONAL ANTIBODY (INFANTS) On August 3rd, the ACIP voted unanimously and recommended the use of Sanofi and AstraZeneca’s Beyfortus™,…

The COVID-19 pandemic brought unprecedented challenges to the healthcare sector, including a surge in vaccine administration errors. As we navigate…

CPP will be attending and exhibiting at the 2025 American Medical Group Association (AMGA) Annual Conference in Grapevine, TX March…

Vaccine uncertainty has led to more individuals questioning vaccines and delaying or refusing vaccines as the pandemic has increased uncertainty…

CPP will be attending and exhibiting at the 2024 AMGA Annual Conference in sunny Orlando, FL April 9-12.  Stop by…

RSV is a significant concern for infants and young children, often leading to hospitalizations. Surveys by the AAP show that…

The United States is witnessing a troubling rise in measles cases, with a significant outbreak in Texas reaching 90 confirmed…

Vaccine Updates – Pfizer Recently, Pfizer communicated some changes to their vaccine portfolio. The addition of Pfizer’s Penbraya™, a new pentavalent…

As winter storms sweep through different parts of the country, maintaining the integrity of vaccines becomes a critical concern for…

Vaccines are a cornerstone of public health, requiring proper storage and handling. In emergencies whether due to natural disasters, power…

Patient recall is an essential part of a practice workflow in healthcare settings. As practices fill schedules this summer scheduling…

Each year, updated immunization schedules provide an important opportunity for pediatric and family medicine practices to reaffirm best practices, align…

Stop by to see CPP as we will be exhibiting at the AAP National Conference & Exhibition September 27th-October 1st,…